A9J-14764-34560
1 vaccination
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 750 / TX
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Survey response — day 21, dose 1MedDRA: Cough, Nasal congestion, Pyrexia, Quarantine, SARS-CoV-2 test positive — Feeling: Fair · Be unable to workFree text: Dry cough, fever up to 100.8 on 1/7/21. 1/8/21 COVID-19 PCR test positive. Fever resolved 1/8 am. Cough much improved. Mild nasal congestion past 3 days. No SOB. 10 day isolation started 1/7/21 PM.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-03-22
Survey response — 3 months, dose 1MedDRA: No adverse event — Feeling: GoodFree text: No symptoms. Wanted to report that I received my second vaccination (Pfizer) on 2/3/2021. Second vaccination delayed due to COVID infection (in isolation). This was reported earlier but did not know how to inform you of my second vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-21
- 2021-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 21, dose 1
Symptoms: Dry cough, fever up to 100.8 on 1/7/21. 1/8/21 COVID-19 PCR test positive. Fever resolved 1/8 am. Cough much improved. Mild nasal congestion past 3 days. No SOB. 10 day isolation started 1/7/21 PM.
Release 6 — 3 months, dose 1
Symptoms: No symptoms. Wanted to report that I received my second vaccination (Pfizer) on 2/3/2021. Second vaccination delayed due to COVID infection (in isolation). This was reported earlier but did not know how to inform you of my second vaccination.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | ○ | ○ | ○ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ○ | ○ | ○ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | No adverse event | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Quarantine | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release